腹腔镜与开腹胃癌根治术治疗进展期胃癌的长期肿瘤学结局:随机对照试验
该随机对照试验纳入328例术前临床分期T2-4aN0-3M0胃癌患者,排除6例未切除肿瘤后,322例随机分为腹腔镜组(162例)和开腹组(160例),最终317例纳入长期分析。结果显示腹腔镜组与开腹组5年总生存率分别为49.0%和50.7%,5年无病生存率分别为47.2%和49.6%,Kaplan-Meier曲线无差异,5年肿瘤复发率无差异。结论认为腹腔镜辅助胃切除术治疗进展期胃癌可提供与开腹手术相当的长期生存,且不增加复发和转移。
要点
- 腹腔镜辅助胃切除术治疗进展期胃癌的5年总生存率与开腹手术相当。
- 两组5年无病生存率和肿瘤复发率无差异。
- 腹腔镜手术未增加进展期胃癌的复发和转移风险。
核心结论
- 腹腔镜辅助胃切除术治疗进展期胃癌可提供与开腹手术相当的长期生存,且不增加复发和转移。
研究设计与样本
- 前瞻性随机对照试验,比较腹腔镜与开腹D2淋巴结清扫胃切除术治疗局部进展期胃癌。
- 2010年1月至2012年6月共纳入328例术前临床分期T2-4aN0-3M0胃癌患者,排除6例未切除肿瘤后,322例随机分为腹腔镜组(162例)和开腹组(160例)。
- 最终317例(腹腔镜组161例,开腹组156例)纳入长期分析,采用意向性治疗原则分析5年总生存率、无病生存率和肿瘤复发。
主要发现
- 腹腔镜组5年总生存率为49.0%,开腹组为50.7%。
- 腹腔镜组5年无病生存率为47.2%,开腹组为49.6%。
- Kaplan-Meier曲线显示两组总生存和无病生存无差异。
- 两组5年肿瘤复发率无差异。
临床怎么用
- 对于术前临床分期T2-4aN0-3M0的进展期胃癌,腹腔镜辅助胃切除术可作为开腹手术的可行选择,长期肿瘤学结局相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopy-assisted gastrectomy is a feasible and safe procedure for treating advanced gastric cancer in terms of short-term outcomes. However, concern about long-term oncologic outcomes has limited the adoption of laparoscopy-assisted gastrectomy for advanced gastric cancer. METHODS: We launched a prospective randomized controlled trial comparing laparoscopic and open gastrectomy with D2 lymph node dissection for locally advanced gastric cancer to evaluate long-term oncologic feasibility. The 5-year overall survival, disease-free survival, and tumor recurrences have been determined on an intention-to-treat basis. RESULTS: Between January 2010 and June 2012, a total of 328 patients with preoperative clinical stage T2-4aN0-3M0 gastric cancer were enrolled in the trial. We excluded 6 patients with unresected tumor, and the remaining 322 patients were randomized to the laparoscopic group (162 patients) or the open group (160 patients) for radical surgery. One patient in laparoscopy-assisted gastrectomy and 4 patients in open gastrectomy were lost to follow-up immediately after discharge, leaving 317 patients (161 in laparoscopy-assisted gastrectomy and 156 in open gastrectomy) eligible for long-term analysis. The 5-year overall survival rate was 49.0% in the laparoscopic group and 50.7% in the open group, and the 5-year disease-free survival rate was 47.2% and 49.6% in the 2 groups, respectively. Kaplan-Meier curves for overall survival and disease-free survival showed no differences between the 2 groups. There was no difference in the 5-year tumor recurrence rate between the 2 procedures. CONCLUSION: Laparoscopy-assisted gastrectomy can provide comparable long-term survival without an increase in recurrence and metastasis in treating advanced gastric cancer.
引用
- Shi Y, Xu X, Zhao Y, et al. Long-term oncologic outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surgery. 2019. PMID: 30772006. doi:10.1016/j.surg.2019.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。